tiprankstipranks
Trending News
More News >
Astrazeneca Plc (AZN)
NASDAQ:AZN
US Market

AstraZeneca (AZN) Ratios

Compare
6,900 Followers

AstraZeneca Ratios

AZN's free cash flow for Q4 2024 was $0.82. For the 2024 fiscal year, AZN's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.93 0.82 0.86 1.16 0.96
Quick Ratio
0.74 0.64 0.68 0.76 0.76
Cash Ratio
0.20 0.19 0.23 0.28 0.39
Solvency Ratio
0.22 0.18 0.14 0.06 0.12
Operating Cash Flow Ratio
0.43 0.34 0.37 0.26 0.24
Short-Term Operating Cash Flow Coverage
5.50 2.02 1.56 2.24 2.15
Net Current Asset Value
$ -37.34B$ -36.90B$ -36.83B$ -39.83B$ -31.55B
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.28 0.30 0.29 0.31
Debt-to-Equity Ratio
0.74 0.73 0.79 0.78 1.30
Debt-to-Capital Ratio
0.42 0.42 0.44 0.44 0.57
Long-Term Debt-to-Capital Ratio
0.39 0.36 0.39 0.43 0.56
Financial Leverage Ratio
2.55 2.58 2.61 2.68 4.27
Debt Service Coverage Ratio
3.97 1.93 1.30 1.39 2.07
Interest Coverage Ratio
5.74 5.16 2.79 0.81 3.95
Debt to Market Cap
0.14 0.13 0.29 0.39 0.34
Interest Debt Per Share
20.50 19.33 19.75 22.62 16.53
Net Debt to EBITDA
1.44 1.64 2.54 4.78 1.55
Profitability Margins
Gross Profit Margin
81.12%82.45%72.06%66.76%80.09%
EBIT Margin
19.29%18.61%8.64%2.70%19.49%
EBITDA Margin
31.66%30.37%20.48%13.66%30.37%
Operating Profit Margin
18.50%17.88%8.47%2.82%19.39%
Pretax Profit Margin
16.07%15.06%5.64%-0.71%14.71%
Net Profit Margin
13.01%13.00%7.41%0.30%12.01%
Continuous Operations Profit Margin
13.02%13.01%7.42%0.31%11.81%
Net Income Per EBT
80.95%86.32%131.47%-42.26%81.61%
EBT Per EBIT
86.88%84.21%66.57%-25.09%75.86%
Return on Assets (ROA)
6.76%5.89%3.41%0.11%4.79%
Return on Equity (ROE)
17.25%15.21%8.88%0.29%20.46%
Return on Capital Employed (ROCE)
13.13%11.61%5.35%1.28%11.12%
Return on Invested Capital (ROIC)
10.30%9.32%6.45%-0.53%8.49%
Return on Tangible Assets
15.35%13.85%8.80%0.26%9.42%
Earnings Yield
3.45%2.83%3.13%0.14%4.87%
Efficiency Ratios
Receivables Turnover
0.00 5.45 6.15 6.20 6.99
Payables Turnover
0.45 2.46 4.86 4.40 2.25
Inventory Turnover
1.93 1.48 2.64 1.38 1.32
Fixed Asset Turnover
4.64 4.36 4.69 3.68 2.98
Asset Turnover
0.52 0.45 0.46 0.36 0.40
Working Capital Turnover Ratio
-14.37 -9.97 -1.77K 25.92 -16.05
Cash Conversion Cycle
-614.25 164.91 122.66 239.59 167.50
Days of Sales Outstanding
0.00 66.98 59.35 58.83 52.19
Days of Inventory Outstanding
189.10 246.24 138.42 263.63 277.18
Days of Payables Outstanding
803.34 148.32 75.12 82.88 161.87
Operating Cycle
189.10 313.22 197.77 322.46 329.37
Cash Flow Ratios
Operating Cash Flow Per Share
7.63 6.62 6.34 4.21 3.66
Free Cash Flow Per Share
4.68 4.20 4.68 2.65 1.67
CapEx Per Share
2.95 2.42 1.66 1.55 1.99
Free Cash Flow to Operating Cash Flow
0.61 0.63 0.74 0.63 0.46
Dividend Paid and CapEx Coverage Ratio
1.29 1.25 1.41 0.98 0.78
Capital Expenditure Coverage Ratio
2.59 2.74 3.81 2.71 1.84
Operating Cash Flow Coverage Ratio
0.39 0.36 0.34 0.19 0.24
Operating Cash Flow to Sales Ratio
0.22 0.23 0.22 0.16 0.18
Free Cash Flow Yield
7.14%6.24%6.90%4.56%3.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.95 35.35 31.92 737.49 20.52
Price-to-Sales (P/S) Ratio
3.77 4.60 2.37 2.21 2.46
Price-to-Book (P/B) Ratio
4.99 5.38 2.83 2.10 4.20
Price-to-Free Cash Flow (P/FCF) Ratio
27.99 32.06 14.50 21.95 29.91
Price-to-Operating Cash Flow Ratio
17.17 20.35 10.70 13.85 13.67
Price-to-Earnings Growth (PEG) Ratio
1.53 0.44 0.01 -7.62 0.15
Price-to-Fair Value
4.99 5.38 2.83 2.10 4.20
Enterprise Value Multiple
13.33 16.77 14.09 20.94 9.67
EV to EBITDA
7.39 9.20 14.09 20.94 9.67
EV to Sales
2.34 2.80 2.89 2.86 2.94
EV to Free Cash Flow
17.38 19.50 17.69 28.45 35.63
EV to Operating Cash Flow
10.66 12.38 13.05 17.95 16.28
Tangible Book Value Per Share
-11.15 -12.14 -14.26 -16.29 -13.07
Shareholders’ Equity Per Share
26.25 25.04 23.93 27.69 11.91
Tax and Other Ratios
Effective Tax Rate
0.19 0.14 -0.32 1.43 0.20
Revenue Per Share
34.80 29.31 28.65 26.39 20.29
Net Income Per Share
4.53 3.81 2.12 0.08 2.44
Tax Burden
0.81 0.86 1.31 -0.42 0.82
Interest Burden
0.83 0.81 0.65 -0.26 0.75
Research & Development to Revenue
0.25 0.24 0.22 0.26 0.23
SG&A to Revenue
0.37 0.42 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.01 0.01 0.02 0.01
Income Quality
1.36 1.50 3.92 -22.50 1.23
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis